159 related articles for article (PubMed ID: 37096473)
1. [New Technologies and Devices of Heart Failure with Reduced Ejection Fraction].
Fan X; He Q; Feng S; Wang J
Zhongguo Yi Liao Qi Xie Za Zhi; 2023 Feb; 47(2):185-189. PubMed ID: 37096473
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
Mann JA; Abraham WT
Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
[TBL] [Abstract][Full Text] [Related]
3. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
[TBL] [Abstract][Full Text] [Related]
4. Role of Cardiac Contractility Modulation in Heart Failure With a Higher Ejection Fraction.
Talha KM; Anker SD; Burkhoff D; Filippatos G; Lam CSP; Stone GW; Wazni O; Butler J
J Card Fail; 2022 Dec; 28(12):1717-1726. PubMed ID: 36122819
[TBL] [Abstract][Full Text] [Related]
5. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
Halbach M; Abraham WT; Butter C; Ducharme A; Klug D; Little WC; Reuter H; Schafer JE; Senni M; Swarup V; Wachter R; Weaver FA; Wilks SJ; Zile MR; Müller-Ehmsen J
Int J Cardiol; 2018 Sep; 266():187-192. PubMed ID: 29705650
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction.
Röger S; Rudic B; Akin I; Shchetynska-Marinova T; Fastenrath F; Tülümen E; Liebe V; El-Battrawy I; Baumann S; Kuschyk J; Borggrefe M
Clin Cardiol; 2018 Apr; 41(4):518-524. PubMed ID: 29697870
[TBL] [Abstract][Full Text] [Related]
7. Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
Coats AJS; Abraham WT; Zile MR; Lindenfeld JA; Weaver FA; Fudim M; Bauersachs J; Duval S; Galle E; Zannad F
Eur J Heart Fail; 2022 Sep; 24(9):1665-1673. PubMed ID: 35713888
[TBL] [Abstract][Full Text] [Related]
8. Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond.
Tschöpe C; Kherad B; Klein O; Lipp A; Blaschke F; Gutterman D; Burkhoff D; Hamdani N; Spillmann F; Van Linthout S
Eur J Heart Fail; 2019 Jan; 21(1):14-22. PubMed ID: 30485591
[TBL] [Abstract][Full Text] [Related]
9. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
Weaver FA; Abraham WT; Little WC; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Madershahian N; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Zile MR
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):320-328. PubMed ID: 28043438
[TBL] [Abstract][Full Text] [Related]
10. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
[TBL] [Abstract][Full Text] [Related]
11. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B
Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077
[TBL] [Abstract][Full Text] [Related]
12. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
[TBL] [Abstract][Full Text] [Related]
13. Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.
Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
Curr Heart Fail Rep; 2016 Apr; 13(2):71-6. PubMed ID: 26879389
[TBL] [Abstract][Full Text] [Related]
14. Cardiac contractility modulation: a novel approach for the treatment of heart failure.
Abi-Samra F; Gutterman D
Heart Fail Rev; 2016 Nov; 21(6):645-660. PubMed ID: 27394714
[TBL] [Abstract][Full Text] [Related]
15. Novel Devices in Heart Failure: BAT, Atrial Shunts, and Phrenic Nerve Stimulation.
Zeitler EP; Abraham WT
JACC Heart Fail; 2020 Apr; 8(4):251-264. PubMed ID: 32241533
[TBL] [Abstract][Full Text] [Related]
16. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.
Pappone C; Augello G; Rosanio S; Vicedomini G; Santinelli V; Romano M; Agricola E; Maggi F; Buchmayr G; Moretti G; Mika Y; Ben-Haim SA; Wolzt M; Stix G; Schmidinger H
J Cardiovasc Electrophysiol; 2004 Apr; 15(4):418-27. PubMed ID: 15089990
[TBL] [Abstract][Full Text] [Related]
17. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure.
Morita H; Suzuki G; Haddad W; Mika Y; Tanhehco EJ; Sharov VG; Goldstein S; Ben-Haim S; Sabbah HN
J Card Fail; 2003 Feb; 9(1):69-75. PubMed ID: 12612875
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of cardiac contractility modulation in heart failure treatment.
Chinyere IR; Balakrishnan M; Hutchinson MD
Curr Opin Cardiol; 2022 Jan; 37(1):30-35. PubMed ID: 34698667
[TBL] [Abstract][Full Text] [Related]
19. [Cardiac contractility modulation in heart failure with reduced ejection fraction treatment].
Chugunov IA; Mareev YV; Fudim M; Mironova NA; Mareev VY; Davtyan RV
Kardiologiia; 2022 Nov; 62(11):71-78. PubMed ID: 36521047
[TBL] [Abstract][Full Text] [Related]
20. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
